Back to Journals » Cancer Management and Research » Volume 14

Cell Differentiation Agent-2 (CDA-2) Inhibits the Growth and Migration of Saos-2 Cells via miR-124/MAPK1 [Retraction]

Authors Li Q, Li G, Liu C, Chen N, Deng B, Xie Y

Received 5 December 2022

Accepted for publication 5 December 2022

Published 6 December 2022 Volume 2022:14 Pages 3419—3420

DOI https://doi.org/10.2147/CMAR.S400292



Li Q, Li G, Liu C, Chen N, Deng B, Xie Y. Cancer Manag Res. 2020;12:4541–4548.

The Editor and Publisher of Cancer Management and Research wish to retract the published article. Concerns were raised regarding the integrity of the published study. The authors were contacted and asked to provide original data that would verify the validity of the reported findings. The authors responded to our queries and provided some data, however much of the expected original data was unavailable and the authors were unable to adequately verify the reported findings. The Editor determined the reported study to be invalid and requested for the article to be retracted. The authors agreed with this decision.

We have been informed in our decision-making by our policy on publishing ethics and integrity and the COPE guidelines on retractions.

The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”.


This retraction relates to this paper


Creative Commons License © 2022 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.